QCLSQ/C Technologies, Inc.
Is Q/C Technologies struggling financially?
Yes, by its own account. Q/C Technologies told the SEC on 15 Apr 2026, in Form 10-K, that there is substantial doubt about its ability to continue as a going concern.
Going concern disclosed Apr 2026
15/100
Critical
- Sector
- Biotech/Pharma
- Market cap
- $21.1M
- Source filing
- 10-K 15 Apr 2026
- Balance sheet
- 30 Jun 2026
Cash runway
-
0months
If the burn speeds up
Empty by Jun 2026
-
1month
If it eases off
Empty by Jul 2026
Both rows are the same reported burn flexed 15% either way, and neither assumes the company raises a cent.
Out of cashTwo years or more
The runway math
Cash and short-term investments
$308K
÷
Cash burned over the last 12 months
$10.8M
What Q/C Technologies told the SEC
…form of assurance about whether such adjustments are appropriate and have been properly applied. Those adjustments were audited by Grassi & Co.,CPAs, P.C. Substantial Doubt About the Company’s Ability to Continue as a Going Concern The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 3 to the consolidated financial…
Q/C Technologies, Inc., Form 10-K, filed 15 Apr 2026.
Read the filing on SEC.govWhat this means
- Not a bankruptcy filing, and not a prediction.
- It is the company’s own statement, agreed with its auditor, that the doubt is material enough to disclose.
- The runway is arithmetic on two reported numbers, not a forecast. Companies carry this language for years, raise money and keep going.
Other Biotech/Pharma companies that filed the doubt
- TCRT Alaunos Therapeutics $4.5M
- BCAB Bioatla $5.3M
- MGRX Mangoceuticals $9.1M
- TPST Tempest Therapeutics $16.6M
- CDT CDT Equity $2.2M
- VTAK Catheter Precision $3.0M